Bavarian Nordic A/S
BAVA
Rang in aandelen
#5061
Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in... Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in the research, production, and global distribution of vital, life-saving vaccines. The company's commercialized offerings include non-replicating vaccines for smallpox and monkeypox, marketed as IMVAMUNE, IMVANEX, and JYNNEOS. Additionally, their portfolio features Rabipur/RabAvert for rabies prevention, Encepur for tick-borne encephalitis, and MVABEA, an Ebola vaccine. Bavarian Nordic also maintains a robust pipeline of investigational treatments. This includes MVA-BN (freeze-dried), which has successfully completed Phase III clinical trials for smallpox; MVA-BN RSV, currently in Phase III development for respiratory syncytial virus; ABNCoV2, which completed Phase II trials targeting SARS-CoV-2; and TAEK-VAC, presently in Phase I/II trials for advanced HER2 and brachyury-expressing cancers. The firm engages in key partnerships, notably a license and collaboration agreement with AdaptVac, and licensing agreements with both the National Cancer Institute and the Public Health Service. Bavarian Nordic operates across a wide international footprint, with a presence in countries such as the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and numerous other global markets.
Aandeelprijs
$37.53
Marktkapitalisatie
$2.85B
Verandering (1 dag)
-0.59%
Verandering (1 jaar)
0.84%
Land
DK
Handel Bavarian Nordic A/S (BAVA)
Categorie
Healthcare
Marktkapitalisatie van Bavarian Nordic A/S(BAVA)
Marktkapitalisatie: $2.85B
Vanaf October 2026 heeft Bavarian Nordic A/S een marktkapitalisatie van $2.85B. Dit maakt Bavarian Nordic A/S volgens onze gegevens het 5061st meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Bavarian Nordic A/S van 2003 tot 2026
BAVA vergeleken met de top 5 populairste stocks
